(MKSI) MKS Instruments - Overview
Stock: Lasers, Controllers, Analyzers, Plating, Sensors
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.83% |
| Yield on Cost 5y | 0.61% |
| Yield CAGR 5y | 0.58% |
| Payout Consistency | 98.7% |
| Payout Ratio | 11.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 47.7% |
| Relative Tail Risk | -5.00% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.48 |
| Alpha | 87.24 |
| Character TTM | |
|---|---|
| Beta | 2.453 |
| Beta Downside | 2.565 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.11% |
| CAGR/Max DD | 0.60 |
Description: MKSI MKS Instruments January 08, 2026
MKS Inc. (NASDAQ:MKSI) delivers core technology components for semiconductor manufacturing, electronics packaging, and specialty industrial markets across North America and Asia-Pacific, operating through three segments: Vacuum Solutions (VSD), Photonics Solutions (PSD) and Material Solutions (MSD).
VSD supplies pressure, flow and gas-delivery hardware, reactive-gas generators, and fiber-optic sensing; PSD offers lasers, beam-profiling tools, precision motion and vibration-isolation systems for advanced PCB and high-density interconnect production; MSD focuses on surface-modification chemistries, electroless/electrolytic plating and finishing services for high-technology equipment.
In FY 2024 the company generated roughly $1.5 billion in revenue, with the Vacuum Solutions segment contributing about 55 % of sales, while PSD and MSD accounted for roughly 30 % and 15 % respectively. Operating margin expanded to 12 % year-over-year, driven by higher fab-capex spending and the ongoing shift toward advanced packaging and heterogeneous integration.
Key macro drivers include the projected $250 billion global semiconductor equipment spend in 2025 and the accelerating demand for 5G, AI and automotive chips, which boost orders for high-precision vacuum and photonics equipment. MKS’s diversified customer base in the United States, China, South Korea, Japan, Taiwan and Singapore helps mitigate regional cyclical risk.
For a deeper quantitative dive into MKSI’s valuation metrics and scenario analysis, the ValueRay platform provides a concise, data-rich overview worth checking out.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 279.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.62 > 1.0 |
| NWC/Revenue: 43.07% < 20% (prev 53.26%; Δ -10.19% < -1%) |
| CFO/TA 0.08 > 3% & CFO 679.0m > Net Income 279.0m |
| Net Debt (3.89b) to EBITDA (878.0m): 4.43 < 3 |
| Current Ratio: 2.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (67.6m) vs 12m ago 0.0% < -2% |
| Gross Margin: 46.96% > 18% (prev 0.47%; Δ 4649 % > 0.5%) |
| Asset Turnover: 43.04% > 50% (prev 39.27%; Δ 3.78% > 0%) |
| Interest Coverage Ratio: 2.35 > 6 (EBITDA TTM 878.0m / Interest Expense TTM 227.0m) |
Altman Z'' 1.95
| A: 0.19 (Total Current Assets 2.54b - Total Current Liabilities 886.0m) / Total Assets 8.78b |
| B: 0.07 (Retained Earnings 618.0m / Total Assets 8.78b) |
| C: 0.06 (EBIT TTM 534.0m / Avg Total Assets 8.90b) |
| D: 0.08 (Book Value of Equity 510.0m / Total Liabilities 6.18b) |
| Altman-Z'' Score: 1.95 = BBB |
Beneish M -3.07
| DSRI: 0.93 (Receivables 611.0m/609.0m, Revenue 3.83b/3.54b) |
| GMI: 1.01 (GM 46.96% / 47.33%) |
| AQI: 1.00 (AQ_t 0.59 / AQ_t-1 0.59) |
| SGI: 1.08 (Revenue 3.83b / 3.54b) |
| TATA: -0.05 (NI 279.0m - CFO 679.0m) / TA 8.78b) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of MKSI shares?
Over the past week, the price has changed by +3.21%, over one month by +32.40%, over three months by +56.74% and over the past year by +118.85%.
Is MKSI a buy, sell or hold?
- StrongBuy: 7
- Buy: 4
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MKSI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 232.2 | -4.4% |
| Analysts Target Price | 232.2 | -4.4% |
| ValueRay Target Price | 273.9 | 12.7% |
MKSI Fundamental Data Overview January 31, 2026
P/E Forward = 9.901
P/S = 4.2749
P/B = 6.3005
P/EG = 0.61
Revenue TTM = 3.83b USD
EBIT TTM = 534.0m USD
EBITDA TTM = 878.0m USD
Long Term Debt = 4.25b USD (from longTermDebt, last quarter)
Short Term Debt = 82.0m USD (from shortTermDebt, last quarter)
Debt = 4.58b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.89b USD (from netDebt column, last quarter)
Enterprise Value = 20.27b USD (16.38b + Debt 4.58b - CCE 697.0m)
Interest Coverage Ratio = 2.35 (Ebit TTM 534.0m / Interest Expense TTM 227.0m)
EV/FCF = 38.24x (Enterprise Value 20.27b / FCF TTM 530.0m)
FCF Yield = 2.61% (FCF TTM 530.0m / Enterprise Value 20.27b)
FCF Margin = 13.83% (FCF TTM 530.0m / Revenue TTM 3.83b)
Net Margin = 7.28% (Net Income TTM 279.0m / Revenue TTM 3.83b)
Gross Margin = 46.96% ((Revenue TTM 3.83b - Cost of Revenue TTM 2.03b) / Revenue TTM)
Gross Margin QoQ = 46.66% (prev 46.56%)
Tobins Q-Ratio = 2.31 (Enterprise Value 20.27b / Total Assets 8.78b)
Interest Expense / Debt = 1.16% (Interest Expense 53.0m / Debt 4.58b)
Taxrate = 11.90% (10.0m / 84.0m)
NOPAT = 470.4m (EBIT 534.0m * (1 - 11.90%))
Current Ratio = 2.86 (Total Current Assets 2.54b / Total Current Liabilities 886.0m)
Debt / Equity = 1.76 (Debt 4.58b / totalStockholderEquity, last quarter 2.60b)
Debt / EBITDA = 4.43 (Net Debt 3.89b / EBITDA 878.0m)
Debt / FCF = 7.34 (Net Debt 3.89b / FCF TTM 530.0m)
Total Stockholder Equity = 2.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.13% (Net Income 279.0m / Total Assets 8.78b)
RoE = 11.35% (Net Income TTM 279.0m / Total Stockholder Equity 2.46b)
RoCE = 7.96% (EBIT 534.0m / Capital Employed (Equity 2.46b + L.T.Debt 4.25b))
RoIC = 6.83% (NOPAT 470.4m / Invested Capital 6.88b)
WACC = 11.90% (E(16.38b)/V(20.97b) * Re(14.95%) + D(4.58b)/V(20.97b) * Rd(1.16%) * (1-Tc(0.12)))
Discount Rate = 14.95% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.37%
[DCF Debug] Terminal Value 64.41% ; FCFF base≈477.6m ; Y1≈460.5m ; Y5≈453.4m
Fair Price DCF = 10.37 (EV 4.58b - Net Debt 3.89b = Equity 696.2m / Shares 67.2m; r=11.90% [WACC]; 5y FCF grow -4.82% → 2.90% )
EPS Correlation: -40.63 | EPS CAGR: -52.88% | SUE: -4.0 | # QB: 0
Revenue Correlation: 52.94 | Revenue CAGR: 7.10% | SUE: 1.15 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.89 | Chg30d=+0.097 | Revisions Net=+6 | Analysts=10
EPS next Year (2026-12-31): EPS=9.07 | Chg30d=+0.328 | Revisions Net=+8 | Growth EPS=+15.1% | Growth Revenue=+8.9%